We use liposomal glutathione powered by Capsoil nanotechnology, which shrinks particles to the nanometer scale and wraps them in a protective lipid layer
In order for GLP-1s to gain FDA approval for this use, they must go through two well-designed (large, randomized, double-blind, placebo-controlled) phase 3 clinical trials that, ideally, run for 6 to 12 months
GLP-1 medications have quickly become one of the most talked-about breakthroughs in medical weight loss
Figure 5 illustrates the antidiabetic mechanism of polyphenols in the human body, showing deconjugation in the gastrointestinal tract, absorption, hepatic portal circulation, reconjugation in the liver, biliary excretion, renal excretion, and microbial deconjugation in the colon, ultimately leading to fecal excretion
This enhances the bioavailability and efficacy of the product